Jonathan Barratt, PhD, FRCP - The Gut–Kidney Axis and Beyond in IgA Nephropathy: A New Frontier in Precision Therapy
Update: 2025-09-30
Description
Visit https://www.peervoice.com/HCJ860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - The Gut–Kidney Axis and Beyond in IgA Nephropathy: A New Frontier in Precision Therapy”, participants will be able to: Explain the pathophysiological significance of the gut–kidney axis in IgA nephropathy (IgAN), including the rationale for targeting the mucosal immune system; Appraise the data from clinical trials examining the safety and efficacy of new therapies in the management of IgAN; and Evaluate data associated with approved therapies, in the context of proposed KDIGO recommended treatment targets and approved therapies, in the management of IgAN.
Comments 
In Channel







